Alprazolam Abuse Liability in Post Traumatic Stress Disorder (PTSD)

创伤后应激障碍 (PTSD) 中阿普唑仑滥用的责任

• 批准号: 7628407
• 负责人: JOHN D ROACHE
• 金额: $ 17.93万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-06-01 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7628407
• 关键词: Address; Affect; Alcohol dependence; Alcohols; Alprazolam; Anxiety; Behavior; Benzodiazepines; Chronic; Clinical; Clinical Research; Code; Comorbidity; Cues; Data; Dependence; Diagnosis; Discrimination; Distress; Dose; Double-Blind Method; Drug Controls; Drug abuse; Drug usage; Endocrine; Esthesia; Event; Exposure to; Frequencies; Goals; Hand; Hospitalization; Human; Individual; Laboratories; Laboratory Procedures; Laboratory Study; Letters; Life; Measures; Methods; Nature; Outpatients; Patients; Pharmaceutical Preparations; Placebos; Post-Traumatic Stress Disorders; Price; Procedures; Psychological reinforcement; Recruitment Activity; Reporting; Research; Research Personnel; Sampling; Self Administration; Self Medication; Stress; Study Subject; Substance abuse problem; Symptoms; Testing; Therapeutic; Trauma; base; behavioral pharmacology; capsule; conditioning; experience; flexibility; high risk; improved; interest; preference; research study; response; sedative; theories; willingness

DESCRIPTION (provided by applicant): This is the second revision of application for an exploratory R21 study by a junior clinician-investigator. The goal of the study is to identify conditions under which we can demonstrate stress-induced alprazolam self-administration in patients with post-traumatic stress disorder (PTSD). PTSD is characterized by chronic anxiety and distress following a life-threatening experience. There also is a high frequency of occurrence of comorbid substance abuse and dependence, particularly with alcohol and other sedatives including benzodiazepines. We have strong preliminary data showing that PTSD patients with comorbid alcohol dependence report increased anxiety when listening to a personalized description of their traumatic experience. They also report an increased preference for alcohol and a willingness to spend money to obtain alcohol; however, they do not show an increase in preference for the benzodiazepine, alprazolam. The current application explores the testing of higher doses of alprazolam than previously tested and utilizes experimental conditions we believe are more likely to reveal increased alprazolam preference. The Specific Aim is to demonstrate stress-induced alprazolam self-administration in PTSD in response to experimentally- induced traumatic anxiety. We hypothesize that inducing trauma-related anxiety will result in larger increases in alprazolam preference in comparison to neutral control conditions. Using procedures we have applied previously in other studies, patients diagnosed with both PTSD and alcohol dependence will be recruited for a research study requiring hospitalization for seven days. Following a familiarization day, subjects will receive four daily "Sampling" exposures to double-blind, letter-coded alprazolam or placebo capsules after listening to descriptions of their trauma or descriptions of a personalized, non-arousing situation. Then, on the last two days of the study, subjects will again be re-exposed to the traumatic and non-arousing scenes and be asked to rate their preference for the letter-coded drugs. Preference will be measured by asking subjects to make choices between letter- coded drugs and various amounts of money. The price at which subjects switch their choices from money to drug will be used as a measure of their preference for drug. Our hypothesis will be supported if subjects spend more for alprazolam than placebo following trauma descriptions and if they spend more for alprazolam after trauma descriptions than after descriptions of non-arousing scenes. This study will help us understand the reasons some emotionally traumatized people abuse drugs, including prescription drugs used to control anxiety. This will help guide doctors in safely using medications to calm the anxiety of trauma victims without leading to drug abuse.

描述（由申请人提供）：这是初级临床医生-研究者对探索性R21研究申请的第二次修订。这项研究的目的是确定条件下，我们可以证明压力诱导阿普唑仑自我管理的创伤后应激障碍（PTSD）患者。创伤后应激障碍的特征是在生命受到威胁的经历之后的慢性焦虑和痛苦。合并药物滥用和依赖的发生率也很高，特别是酒精和其他镇静剂（包括苯二氮卓类药物）。我们有强有力的初步数据显示，患有酒精依赖的PTSD患者在听到个性化的创伤经历描述时，焦虑感会增加。他们还报告了对酒精的偏好增加，并愿意花钱购买酒精;然而，他们对苯二氮卓类药物阿普唑仑的偏好没有增加。本申请探索了比先前测试的更高剂量的阿普唑仑的测试，并利用我们认为更可能揭示阿普唑仑偏好增加的实验条件。具体目的是证明应激诱导的阿普唑仑自我给药在PTSD中对实验诱导的创伤性焦虑的反应。我们假设，与中性对照条件相比，诱导创伤相关焦虑将导致阿普唑仑偏好的较大增加。使用我们以前在其他研究中应用的程序，诊断为创伤后应激障碍和酒精依赖的患者将被招募参加一项需要住院7天的研究。在熟悉日之后，受试者将在听取对其创伤的描述或对个性化的非唤醒情况的描述后，接受每日四次的双盲、字母编码的阿普唑仑或安慰剂胶囊的“采样”暴露。然后，在研究的最后两天，受试者将再次接触创伤性和非唤起性的场景，并被要求评价他们对字母编码药物的偏好。通过要求受试者在字母编码的药物和各种金额之间做出选择来测量偏好。受试者将其选择从金钱转向药物的价格将被用作他们对药物偏好的衡量标准。如果受试者在创伤描述后阿普唑仑的花费高于安慰剂，并且如果他们在创伤描述后阿普唑仑的花费高于非唤起场景的描述，则我们的假设将得到支持。这项研究将帮助我们了解一些情感创伤的人滥用药物的原因，包括用于控制焦虑的处方药。这将有助于指导医生安全地使用药物来平息创伤受害者的焦虑，而不会导致药物滥用。